Detalles de la búsqueda
1.
Clinical response correlates with 4-week postinjection ustekinumab concentrations in patients with moderate-to-severe psoriasis.
Br J Dermatol
; 182(2): 390-397, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31004510
2.
Development and User Experiences of a Biopsychosocial Interprofessional Online Course on Persistent Somatic Symptoms.
Front Psychiatry
; 12: 725546, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34819884
3.
Exploring temporal relationships among worrying, anxiety, and somatic symptoms.
J Psychosom Res
; 146: 110293, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33228967
4.
Development of sandwich-type ELISAs for the quantification of rat and murine thrombin activatable fibrinolysis inhibitor in plasma.
J Thromb Haemost
; 6(1): 132-8, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17922808
5.
Early serial trough and antidrug antibody level measurements predict clinical outcome of infliximab and adalimumab treatment.
Gut
; 61(2): 321; author reply 322, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21330576
6.
Individual variation in temporal relationships between exposure to radiofrequency electromagnetic fields and non-specific physical symptoms: A new approach in studying 'electrosensitivity'.
Environ Int
; 121(Pt 1): 297-307, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30227317
7.
Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response.
Aliment Pharmacol Ther
; 47(3): 346-355, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29226370
8.
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.
Acta Gastroenterol Belg
; 81(1): 15-21, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29562373
9.
Comparative evaluation of stable TAFIa variants: importance of alpha-helix 9 and beta-sheet 11 for TAFIa (in)stability.
J Thromb Haemost
; 5(10): 2105-12, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17666015
10.
Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study.
Aliment Pharmacol Ther
; 45(7): 923-932, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28164321
11.
Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.
J Thromb Haemost
; 15(11): 2218-2225, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28834317
12.
Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice.
J Thromb Haemost
; 15(12): 2432-2442, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28981198
13.
Characterization of rat thrombin-activatable fibrinolysis inhibitor (TAFI)--a comparative study assessing the biological equivalence of rat, murine and human TAFI.
J Thromb Haemost
; 4(11): 2470-7, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17002650
14.
The pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of monoclonal antibodies as PAI-1 inhibitors.
Verh K Acad Geneeskd Belg
; 68(3): 179-98, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16796017
15.
Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience.
Aliment Pharmacol Ther
; 44(7): 673-83, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27502581
16.
The importance of helix F in plasminogen activator inhibitor-1.
Biochim Biophys Acta
; 1476(1): 20-6, 2000 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-10606763
17.
Characterization of plasminogen activator inhibitor 1 mutants containing the P13 to P10 region of ovalbumin or antithrombin III: evidence that the P13 residue contributes significantly to the active to substrate transition.
Biochim Biophys Acta
; 1387(1-2): 291-7, 1998 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-9748634
18.
Modulation of TAFI function through different pathways--implications for the development of TAFI inhibitors.
J Thromb Haemost
; 3(12): 2745-53, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16359512
19.
Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.
J Mol Biol
; 297(3): 683-95, 2000 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-10731421
20.
Ara h 1 protein-antibody dissociation study: evidence for binding inhomogeneities on a molecular scale.
N Biotechnol
; 32(5): 458-66, 2015 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-25686720